Coeptis Therapeutics proceeds with 1-for-20 reverse stock split; effective after Dec 30

Z Squared Inc.

Reverse split ratio set at 1-for-20; effective after market close Dec 30, post-split trading begins Dec 31.
No fractional shares issued; fractional holdings rounded up to whole share.
Split intended to help meet Nasdaq $1.00 minimum bid price requirement.
Stockholder ownership percentage unchanged except for fractional rounding adjustments.
CUSIP changes to 19207A 207; par value remains $0.0001.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Z Squared Inc.: Added Article IV.D to effect a 20-to-1 reverse stock split of common stock, effective 5:00 P.M. Eastern Time on December 30, 2024 (effective 2024-12-30).

Change: charter amendment
Effective: 2024-12-30

Exact text from the filing

Article IV of the Certificate of Incorporation is hereby amended by adding the following paragraph as a new Article IV.D: “D. Effective as of 5:00 P.M., Eastern Time, on December 30, 2024 (the “Effective Time”), each twenty (20) outstanding shares of the Corporation’s Common Stock, par value $0.0001 per share, shall automatically and without any action on the part of the respective holders thereof be exchanged and combined into one (1) share of Common Stock, par value $0.0001 per share. At the Effective Time, there shall be no change in the number of authorized shares that the Corporation shall have the authority to issue. No fractional shares shall be issued in connection with the exchange. In lieu thereof, any person who holds a fraction of one (1) share of Common Stock after the exchange shall be entitled to receive one (1) share of Common Stock.”

View on SEC.gov

83 governance changes filed in the last 30 days. Browse all governance changes →

Z Squared Inc. filing history →

Source: SEC EDGAR

accession 0001683168-24-009012

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.